CNDO Key Stats
- Coronado Biosciences Inc. Enters Oversold Territory Nov 29
- Coronado Biosciences Inc. Enters Oversold Territory - Tale of the Tape Zacks Nov 29
- 4 Stocks Under $10 Moving Higher The Street Nov 27
- The 5 Dumbest Things on Wall Street Holiday Quiz Nov 22
- Notable 52-Week Highs and Lows of the Day 11/15: (VNDA) (CADX) (P) High; (SANW) (CNDO) Low Street Insider Nov 15
- CORONADO BIOSCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 7
- MARKET PULSE-Agenus, Dexcom, American Eagle, Noodles, Transocean Nov 7
- Coronado Biosciences (CNDO) to Halt TRUST-II Study Street Insider Nov 7
- Coronado Biosciences Announces Independent Data Monitoring Committee Recommendation to Discontinue Falk Phase 2 Trial of TSO in Crohn's Disease GlobeNewswire Nov 7
- CORONADO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi Nov 6
CNDO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Coronado Biosciences is down 63.38% over the last year vs S&P 500 Total Return up 30.02%, Actelion up 72.20%, and Jazz Pharmaceuticals up 119.6%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Balance Sheet View Statement
Pro Ratings for CNDO
Pro Strategies Featuring CNDO
Did Coronado Biosciences make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Coronado Biosciences Inc is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer.